Related Experiment Video
Updated: May 6, 2026

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Biomarkers in schizophrenia: a brief conceptual consideration
Cynthia S Weickert1, Thomas W Weickert, Anil Pillai
1School of Psychiatry, University of New South Wales, Randwick, NSW 2031, Australia ; Neuroscience Research Australia, Hospital Road, Randwick, NSW 2031, Australia ; Schizophrenia Research Institute, Darlinghurst, NSW 2010, Australia.
Schizophrenia research has long sought diagnostic biomarkers, but none currently exist. Future biomarkers will likely identify multiple disease subtypes due to schizophrenia
Area of Science:
- Neuroscience
- Psychiatry
- Biomarker Research
Background:
- Decades of schizophrenia research have focused on identifying reliable biomarkers.
- The clinical utility of biomarkers for schizophrenia remains largely unrealized.
- Understanding the challenges in biomarker discovery is crucial for advancing the field.
Purpose of the Study:
- To explore the conceptual challenges hindering the development of diagnostic biomarkers for schizophrenia.
- To critically examine the definition and application of biomarkers in schizophrenia research.
- To address key questions regarding the need, definition, utility, and current existence of schizophrenia biomarkers.
Main Methods:
- Conceptual analysis of biomarker definitions and their application to schizophrenia.
- Review of existing literature and research paradigms in schizophrenia biomarker discovery.
- Discussion of the heterogeneity of schizophrenia and its implications for biomarker development.
Main Results:
- Currently, no definitive diagnostic biomarker for schizophrenia exists.
- The heterogeneity of schizophrenia necessitates a multi-biomarker approach targeting diverse pathophysiological processes.
- Existing definitions and research approaches may not adequately capture the complexity of schizophrenia.
Conclusions:
- Significant challenges impede the realization of diagnostic biomarkers for schizophrenia.
- Future progress requires acknowledging and addressing the heterogeneity of the disorder.
- Substantial further research is needed to establish well-validated biomarkers for schizophrenia.
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...

